The Price is Right……Or Is It? Budgeting for Drug Development Without Breaking the Bank or Your Molecule
When it comes to injectable drug development, “price” is never just a number. It’s a strategic decision. For early-stage biopharma companies, budgets are more than tight - they’re make-or-break. Every dollar spent can either accelerate a program to IND or drain resources from the next critical milestone. But in a world…